Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "Formulation"

1122 News Found

Eris Lifesciences reports Q4 FY26 revenue of Rs. 757 crore; PAT jumps 173%
News | May 21, 2026

Eris Lifesciences reports Q4 FY26 revenue of Rs. 757 crore; PAT jumps 173%

Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth


Amita Patni appointed VP- Global Procurement Head at Shalina Healthcare
People | May 20, 2026

Amita Patni appointed VP- Global Procurement Head at Shalina Healthcare

She brings extensive expertise in managing global and domestic procurement operations


Pfizer promotes Ashish Doshi as Director at IITM RP, Chennai
People | May 19, 2026

Pfizer promotes Ashish Doshi as Director at IITM RP, Chennai

Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations


Zeus Hygia launches Metaberine in Europe and US markets
Healthcare | May 19, 2026

Zeus Hygia launches Metaberine in Europe and US markets

Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management


Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization
Supply Chain | May 19, 2026

Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization

Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets


HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
News | May 19, 2026

HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity

Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026


Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer
Biopharma | May 19, 2026

Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer

Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs


Alembic Pharmaceuticals posts strong Q4 FY26 growth as net profit jumps 29%
News | May 18, 2026

Alembic Pharmaceuticals posts strong Q4 FY26 growth as net profit jumps 29%

US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya


Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%
News | May 18, 2026

Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%

FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies